Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate

Teva and mAbxience enter into a strategic global partnership for in-licensing of an oncology biosimilar candidate



Agreement signals a major step in mAbxience's global expansion strategy and...

Related Keywords

Argentina ,Spain ,United States ,America ,Jurgen Van Broeck ,Insud Pharma ,Fresenius Kabi ,Linkedin ,Teva Pharmaceuticals International Gmb ,Contract Development ,Teva Pharmaceutical Industries Ltd ,Manufacturing Organization ,Business Development At Teva ,Teva Pharmaceuticals International Gmbh ,Teva Pharmaceutical Industries ,Good Manufacturing Practice ,Angus Grant ,Executive Vice President ,Business Development ,Global Commercial Director ,South America ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,